# Tranexamic Acid in Adult Spinal Deformity Surgery

> **NCT03553186** · PHASE3 · RECRUITING · sponsor: **Hospital for Special Surgery, New York** · enrollment: 100 (estimated)

## Conditions studied

- Spinal Deformity
- Degenerative Lumbar Spinal Stenosis
- Blood Loss, Surgical

## Interventions

- **DRUG:** Tranexamic Acid 100 MG/ML
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03553186
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03553186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03553186, "Tranexamic Acid in Adult Spinal Deformity Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03553186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*